Trial intelligence / Profile preview

PK/PD of Propofol in Morbidly Obese Patients

NCT00395681Phase 4Completed

Start
Sep 2007
Primary completion
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of propofol in class III obesity (2 arms). Primary endpoints: Clearance, Intercompartmental Clearance and 2 more. Started Sep 2007; status: completed.

02

Drugs

propofol
03

Conditions

class III obesity

Beyond the preview

Go deeper on NCT00395681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00395681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call